Home   About this service   Get the news  
+32 2 743 34 03

 
UCB [BE0003739530 / UCB]

UCB Media Room: Disposals of own shares

INFORMATION REGLEMENTEE


[30/10/2020 | 20:04]
https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513=
9PTmAm2ORJ-2Fb7C-2B6elpSM-2FNNaVRXejC10C7GgVsE4CK8r9fB21-2F2Wg0dXx0FXFRCnX5=
GQbWXvet4dwV1DyOjOtK-2BerSOBgpAak6aMl-2FgNXD_xDPID0vOuylFAU8fv4e60wei4JxqEG=
BdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2=
X9c9g1wbAm8OmjSYqr6TXas9aa-2FLR0jP3Dn3jiYzIk9yfymZ2Jos-2BP4seJyaGkc8TdL8ksM=
moCT96cwsc25f2YWJdfvCrGtAAheQ8ZhfyWDbQpVdvh5TV-2FlWbg6sY0kK-2FNFwRWJwLeYL04=
fX5t21K7-2FQpNT0n-2FKeGtmEk4pHwjf0UNATrntkWklvLftzidC61tSfoDrbgonJYYQ2q6110=
PG5IHJFaks2CTcwR6oesiy6EwjW8n8CU5-2FhJpRVMGnB51yqnZbA-3D

** Disposals of own shares
------------------------------------------------------------

Brussels (Belgium), 30 October 2020 =E2=80=93 20:00 (CET) =E2=80=93 regulat=
ed information

In accordance with article 8:6 of the Royal Decree executing the Belgian Co=
de of Companies and Associations, UCB SA/NV (=E2=80=9CUCB=E2=80=9D or the =
=E2=80=9CCompany) (Euronext Brussels: UCB) announces that, following exerci=
ses of stock options by members of its personnel, it has disposed of UCB sh=
ares OTC in view of deliveries of these shares to the relevant members of t=
he personnel, within the framework of the Long Term Incentive Program of th=
e UCB Group, as follows:

https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513=
9PTmAm2ORJ-2Fb7C-2B6elpSM-2FNNaVRXejC10C7GgVsTBJeSit5U7Jw0swJyxKM5S827lJ8ed=
eQq9oUzI7EvPFz7-2BFb3oGOYQn7UfgySK3l982x_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVW=
u7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9=
g1wbAm8OmjSYqr6TXas9aa-2FLR0jP3Dn3jiYzIk9yfymZ2Jos-2BP4seJyaGkc8TdL8ksMmoCT=
96cwsc25f2YWJdfvCrGtAAheQ8ZhfyWDbQpVdvh43Ta3KqgTJTxlmKpsaxpvvFSyVFqnr2yfMux=
nlF2lpkKonvnT19eaXgu1K6L5q4EYXaxCp8Tu0fFpLkJqfUpSUlWyJmGitjPLMybH8gV5273EWu=
90P9dkuUhR0DnGddI6kYoQBa5OfAJz-2Fcgk7nhxg-3D

This press release is available on UCB SA/NV=E2=80=99s website via the foll=
owing link (https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQ=
yQ53jATUXZJD59ZUodhGC-2FyJVE-2BjXw-2Fd0j1C70r-2FZ058zOLCiGbx-2FzvKhSzxYKNx1=
8dK5MiuQ-3D-3DYduI_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bS=
l0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wbAm8OmjSYqr6TXas9aa=
-2FLR0jP3Dn3jiYzIk9yfymZ2Jos-2BP4seJyaGkc8TdL8ksMmoCT96cwsc25f2YWJdfvCrGtAA=
heQ8ZhfyWDbQpVdvh8s1cH9QetGgKRDYwVC0Cv7xW-2BhX9mE5XR6I3vkYgRMRe2iZmWmmVZd2y=
OHObh5hJWq2Y8FJ-2BeebLvqLUoNPlxMmQDNtbTnoud1WN65OybtpeoYyxC7oFWWzrLO1PGrmTU=
VOy-2BBFMXGgBDBXMKSXA40-3D .

Investor Relations
Antje Witte =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0
Investor Relations, UCB
T +32.2.559.94.14 antje.witte@ucb.com

Isabelle Ghellynck,
=C2=A0Investor Relations, UCB
T+32.2.559.9588, isabelle.ghellynck@ucb.com=C2=A0

About UCB
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company =
focused on the discovery and development of innovative medicines and soluti=
ons to transform the lives of people living with severe diseases of the imm=
une system or of the central nervous system. With 7 500 people in approxima=
tely 40 countries, the company generated revenue of =E2=82=AC 4.9 billion i=
n 2019. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twit=
ter: @UCB_news

GenericFile
201030 - Disposals of own shares (https://u7061146.ct.sendgrid.net/ls/click=
?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6elpSM-2FNNaVRXejC10C7=
GgVspchFu10ZIycQNd-2FQpI9bFFsiGz3wuZ1d-2BL7wgwCs1uI-3DNJ0d_xDPID0vOuylFAU8f=
v4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeo=
COG9ekocVj-2F2X9c9g1wbAm8OmjSYqr6TXas9aa-2FLR0jP3Dn3jiYzIk9yfymZ2Jos-2BP4se=
JyaGkc8TdL8ksMmoCT96cwsc25f2YWJdfvCrGtAAheQ8ZhfyWDbQpVdvhwZ-2BHlDTOfXEf2abH=
yhjlmD2-2BS9Tse2uGX4quRpGE2RJvswUGdibU1KZhCMrxRc8-2FGaaW57cDtml2e5P30YO12vc=
dtqigCTAck1wpDQT0L1vRrKKNlJ3kAsC60Kyc0CgitQTLXwtJna52QMOfhap6NY-3D GenericF=
ile
201030 - Ali=C3=A9nation d actions propres (https://u7061146.ct.sendgrid.ne=
t/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6elpSM-2FNNa=
VRXejC10C7GgVsBIS2dXILqy6TBVp4u64Dcxbw1GDZavw0KcgnNcCE190-3DWG-m_xDPID0vOuy=
lFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf=
-2FOeoCOG9ekocVj-2F2X9c9g1wbAm8OmjSYqr6TXas9aa-2FLR0jP3Dn3jiYzIk9yfymZ2Jos-=
2BP4seJyaGkc8TdL8ksMmoCT96cwsc25f2YWJdfvCrGtAAheQ8ZhfyWDbQpVdvhyUabbjH3ScG6=
948hBHIQAdkJptdX5Tx2wUsGDiHSJCrHYBlwiByAtBHrPUbshJSl-2Fcmc-2BpTIh6dNplc7Tjb=
lt21q1b5WGXVNUyDS7MU3-2FB4e7DTUrbMAuqgegCqSnrqX5PNbrQKZqsFsB8t31PJUhw-3D Ge=
nericFile
201030 - Vervreemding van eigen aandelen (https://u7061146.ct.sendgrid.net/=
ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6elpSM-2FNNaVR=
XejC10C7GgVsTV6ppmgEb3CnNftHBScgigjw5UuzF65gXbC2jTjVOSk-3D0Unv_xDPID0vOuylF=
AU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2=
FOeoCOG9ekocVj-2F2X9c9g1wbAm8OmjSYqr6TXas9aa-2FLR0jP3Dn3jiYzIk9yfymZ2Jos-2B=
P4seJyaGkc8TdL8ksMmoCT96cwsc25f2YWJdfvCrGtAAheQ8ZhfyWDbQpVdvhwb5q31914KyxvT=
46b3MdBBSdtBrmhbWS92AGPbdbRsfWAfeFb7V6PapBZqnChkSLo16tPfeHwisKyAdzg2PMlq7UF=
YJM9M5KyRiQhOwKI-2Bsh4kbHX6rVIlqD8apeMJeWyuroDkhs8uSozyiWtwgXco-3D Image
Chart 1 October 30 2020 (https://u7061146.ct.sendgrid.net/ls/click?upn=3D4t=
NED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6elpSM-2FNNaVRXejC10C7GgVsTBJeS=
it5U7Jw0swJyxKM5QUBWAsin94vZiam2PiEq-2BE-3DC4yg_xDPID0vOuylFAU8fv4e60wei4Jx=
qEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-=
2F2X9c9g1wbAm8OmjSYqr6TXas9aa-2FLR0jP3Dn3jiYzIk9yfymZ2Jos-2BP4seJyaGkc8TdL8=
ksMmoCT96cwsc25f2YWJdfvCrGtAAheQ8ZhfyWDbQpVdvh-2BZOMCQu1aCHso8zxaiSfnK0daUI=
qBWYLmcJuvgE9NJV-2BwGvyttCrdONd-2FnKxRmc-2Fi3aFuGHK-2BOOODlpuotA9FM5hAPClB2=
TIanNvv1SjSLbOdnnVk8pSgrLrqBANrdHzrqum3cDtpyUKVZjwoZBdSc-3D=0D
=0D
______________________=0D
If you would rather not receive future communications from UCB SA, please g=
o to https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jAT=
UeYfdhr1xEBQnaPhR2RKx1tfe2VKDZTewv5u80JomRcXnljdnwEf-2Fde9nhqcEMfRPrgHPGRjJ=
Y0GNsF8pNESZYVyY2WyLF02cDSoV-2BAML6ekdCEYuasUBypN1Bdhxh4JHoCwej9Be6Zg1i2xvs=
fWqiw-3DV89r_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvP=
s6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wbAm8OmjSYqr6TXas9aa-2FLR0=
jP3Dn3jiYzIk9yfymZ2Jos-2BP4seJyaGkc8TdL8ksMmoCT96cwsc25f2YWJdfvCrGtAAheQ8Zh=
fyWDbQpVdvhwyA5mwL2oqKbIH-2BpKe1VvA7KghHUWve7lrW1F8OkeMTr1kbssgGPyCX6JWNCYA=
euPbdWCTDQtYPBcNSyNfmlrtcFGjZYsaYtYRUs0MD-2FJVQenCmkiS4WTufjkfY8dvm8gbKzpoy=
8Sjg7Yopbubv4gU-3D=0D
UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium=